Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06546839Completed
Randomised, single-blind trial of bupivacaine in postoperative pain (2 arms), sponsored by Istanbul Medipol University. Primary endpoint: Opioid consumption (Fentanyl PCA) at 24 hours. Started Aug 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06546839.